Friday, October 3, 2025

1:25 PM - 1:45 PM

---

Speaker(s)

Presented by: Dr. David Tsui

---

Session Details

By the end of this session participants will be able to: 1. Discuss the sensitivity and specificity of blood-based testing in the detection of rare molecular subtypes of lung cancer, including mutations and fusions 2. Discuss the role of liquid biopsy in the treatment of patients with targetable mutations

---

Speaker